![]() |
|
|
This article has been cited by other articles:
![]() |
J.-B. Shen, A. J. Pappano, and B. T. Liang Extracellular ATP-stimulated current in wild-type and P2X4 receptor transgenic mouse ventricular myocytes: implications for a cardiac physiologic role of P2X4 receptors FASEB J, February 1, 2006; 20(2): 277 - 284. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Jarvis, B. Bianchi, J. T. Uchic, J. Cartmell, C.-H. Lee, M. Williams, and C. Faltynek [3H]A-317491, a Novel High-Affinity Non-Nucleotide Antagonist That Specifically Labels Human P2X2/3 and P2X3 Receptors J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 407 - 416. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Khakh, G. Burnstock, C. Kennedy, B. F. King, R. A. North, P. Seguela, M. Voigt, and P. P. A. Humphrey International Union of Pharmacology. XXIV. Current Status of the Nomenclature and Properties of P2X Receptors and Their Subunits Pharmacol. Rev., March 1, 2001; 53(1): 107 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Khakh, W. R. Proctor, T. V. Dunwiddie, C. Labarca, and H. A. Lester Allosteric Control of Gating and Kinetics at P2X4 Receptor Channels J. Neurosci., September 1, 1999; 19(17): 7289 - 7299. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Ralevic and G. Burnstock Receptors for Purines and Pyrimidines Pharmacol. Rev., September 1, 1998; 50(3): 413 - 492. [Abstract] [Full Text] [PDF] |
||||